Barclays analyst Andrew Mok just slapped a Buy rating and a $522 price target on Elevance Health, despite a few warning signs ...

Seeing your biggest competitor fail is the next best thing to achieving success yourself. That’s the story of Elevance Health (ELV) and its ...

Elevance Health's Q1 results showed stable Medicare utilization and reaffirmed guidance. Click here to find out why ELV stock ...

RBC Capital analyst Ben Hendrix maintained a Buy rating on Elevance Health (ELV – Research Report) today and set a price target of $478.00. The ...

The stock's rise snapped a four-day losing streak.

We recently published a list of 10 Best Medical Stocks to Buy According to Billionaires. In this article, we are going to ...

Shares of Elevance Health Inc. ELV rallied 1.11% to $435.68 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index SPX rising 9.52% to ...

Indianapolis-based health Elevance Health’s board is recommending its investors reject a shareholder proposal that asks the health insurance company to provide a report and metrics on the ...

County health departments in Nassau, Suffolk and across the state will be affected by a $300 million funding cut from the federal government, putting mental health and addiction programs at risk ...

Elevance Health (NYSE:ELV) has been analyzed by 5 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. In the table below, you'll find a summary of ...

Elevance Health might have a mountain of debt, but it’s also sitting on a cushion of cold hard cash. At the end of 2024, Elevance had US$33.5b in debt but US$34.7b in cash, giving it net cash of ...

Those three insurers could benefit most from the latest developments, but Elevance Health Inc. (ELV) and Centene Corp. (CNC) also have exposure to the category, according to Hynes. Elevance's ...